Stable [57Co]-bleomycin complex with a very high specific radioactivity for use at very low concentrations.

[1]  D. Sem,et al.  Intracellular DNA strand scission and growth inhibition of Ehrlich ascites tumor cells by bleomycins. , 1990, Cancer research.

[2]  L. Mir,et al.  Transient electropermeabilization of cells in culture. Increase of the cytotoxicity of anticancer drugs. , 1988, Biochemical pharmacology.

[3]  J. Stubbe,et al.  Mechanisms of bleomycin-induced DNA degradation , 1987 .

[4]  D. Petering,et al.  Properties of the initial reaction of bleomycin and several of its metal complexes with Ehrlich cells. , 1986, Cancer research.

[5]  J. Lazo,et al.  Lidocaine potentiation of bleomycin A2 cytotoxicity and DNA strand breakage in L1210 and human A-253 cells. , 1985, Cancer research.

[6]  S. Horwitz,et al.  Characterization of the association of radiolabeled bleomycin A2 with HeLa cells. , 1984, Cancer research.

[7]  A. Nunn.  Interactions between bleomycins and metals. , 1976, The Journal of antibiotics.

[8]  G. Kōsaki,et al.  Intracellular distribution of (14C)bleomycin and the cytokinetic effects of bleomycin in the mouse tumor. , 1976, Cancer research.

[9]  R. Reba,et al.  Distribution of labeled bleomycin in normal and tumor-bearing mice. , 1973, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[10]  M. Watanabe,et al.  Effect of bleomycin on mammalian cell survival. , 1972, Journal of the National Cancer Institute.

[11]  J. L. Biedler,et al.  Cellular resistance to actinomycin D in Chinese hamster cells in vitro: cross-resistance, radioautographic, and cytogenetic studies. , 1970, Cancer research.

[12]  T. Takeuchi,et al.  New antibiotics, bleomycin A and B. , 1966, The Journal of antibiotics.